{"id":43765,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/tender-and-support-agreement-by-armstrong-acquisition-corp.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"tender-and-support-agreement-by-armstrong-acquisition-corp","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/planning\/tender-and-support-agreement-by-armstrong-acquisition-corp.html","title":{"rendered":"Tender and Support Agreement &#8211; By Armstrong Acquisition Corp. &#8211; Acquisition of Micromet, Inc. by Amgen Inc."},"content":{"rendered":"<p align=\"center\"><strong>TENDER AND SUPPORT AGREEMENT <\/strong><\/p>\n<p><strong>T<\/strong><strong>HIS<\/strong><strong><br \/>\nT<\/strong><strong>ENDER<\/strong> <strong>AND<\/strong><strong><br \/>\nS<\/strong><strong>UPPORT<\/strong><strong> A<\/strong><strong>GREEMENT<\/strong><br \/>\n(this <strong><em>&#8220;Agreement&#8221;<\/em><\/strong>) is entered into as of January 25,<br \/>\n2012, by and among Amgen Inc., a Delaware corporation<br \/>\n(<strong><em>&#8220;Parent&#8221;<\/em><\/strong>), Armstrong Acquisition Corp., a Delaware<br \/>\ncorporation and wholly owned subsidiary of Parent<br \/>\n(<strong><em>&#8220;Purchaser&#8221;<\/em><\/strong>), and<br \/>\n(<strong><em>&#8220;Stockholder&#8221;<\/em><\/strong>).<\/p>\n<p align=\"center\">RECITALS<\/p>\n<p><strong>A. <\/strong>Stockholder is a holder of record and the &#8220;beneficial<br \/>\nowner&#8221; (within the meaning of Rule 13d-3 under the U.S. Securities Exchange Act<br \/>\nof 1934, as amended (the <strong><em>&#8220;Exchange Act&#8221;<\/em><\/strong>)) of certain<br \/>\nshares of common stock of Micromet, Inc., a Delaware corporation (the<br \/>\n<strong><em>&#8220;Company&#8221;<\/em><\/strong>).<\/p>\n<p><strong>B. <\/strong>Parent, Purchaser and the Company are entering into an<br \/>\nAgreement and Plan of Merger of even date herewith (as it may be amended from<br \/>\ntime to time, the <strong><em>&#8220;Merger Agreement&#8221;<\/em><\/strong>) which provides,<br \/>\namong other things, for the Purchaser to commence a tender offer (the<br \/>\n<strong><em>&#8220;Offer&#8221;<\/em><\/strong>) for all of the issued and outstanding shares<br \/>\nof common stock, par value $0.00004 per share, of the Company (including any<br \/>\nassociated rights to purchase capital stock issued pursuant to the Company&#8217;s<br \/>\nRights Agreement, the <strong><em>&#8220;Shares&#8221;<\/em><\/strong>) and following the<br \/>\nconsummation of the Offer, the merger of Purchaser with and into the Company,<br \/>\nwith the Company continuing as the surviving corporation (the<br \/>\n<strong><em>&#8220;Merger&#8221;<\/em><\/strong>), upon the terms and subject to the<br \/>\nconditions set forth in the Merger Agreement.<\/p>\n<p><strong>C. <\/strong>As a condition to the willingness of Parent and Purchaser<br \/>\nto enter into the Merger Agreement and as an inducement in consideration<br \/>\ntherefor, Stockholder has agreed to enter into this Agreement and tender and<br \/>\nvote Stockholder&#8217;s Subject Securities (as defined below) as described herein.\n<\/p>\n<p align=\"center\"><strong>AGREEMENT <\/strong><\/p>\n<p>The parties to this Agreement, intending to be legally bound, agree as<br \/>\nfollows:<\/p>\n<p><strong>SECTION 1. CERTAIN DEFINITIONS <\/strong><\/p>\n<p>For purposes of this Agreement:<\/p>\n<p>(a) The terms <strong><em>&#8220;Acquisition Proposal<\/em><\/strong>,<strong><em>&#8221;<br \/>\n&#8220;Affiliate<\/em><\/strong><em>,<strong>&#8221; &#8220;Company Common<br \/>\nStock<\/strong>,<strong>&#8220;<\/strong><\/em> and <strong><em>&#8220;Person<br \/>\n<\/em><\/strong>and other capitalized terms not defined in this Agreement, have<br \/>\nthe respective meanings assigned to those terms in the Merger Agreement.<\/p>\n<p>(b) <strong><em>&#8220;Contract&#8221;<\/em><\/strong> means any note, bond, mortgage,<br \/>\nindenture, lease, license, permit, contract, commitment, arrangement,<br \/>\nunderstanding, agreement or other instrument or obligations of any kind,<br \/>\nincluding, any voting agreement, proxy arrangement, pledge agreement,<br \/>\nstockholder agreement or voting trust, to which Stockholder is a party or by<br \/>\nwhich the Subject Securities are bound.<\/p>\n<p>(c) <strong><em>&#8220;Encumbrance&#8221;<\/em><\/strong> means any lien, pledge,<br \/>\nhypothecation, security interest, option, right of first refusal, proxies,<br \/>\nvoting trusts or agreements, or other encumbrance (other than as created by this<br \/>\nAgreement or restrictions on transfer under the U.S. Securities Act of 1933, as<br \/>\namended).<\/p>\n<p>(d) Stockholder is deemed to <strong><em>&#8220;Own&#8221;<\/em><\/strong> or to have<br \/>\nacquired <strong><em>&#8220;Ownership&#8221;<\/em><\/strong> of a security if Stockholder: (i)<br \/>\nis the record owner of such security; or (ii) is the &#8220;beneficial owner&#8221; (within<br \/>\nthe meaning of Rule 13d-3 under the Exchange Act) of such security.<\/p>\n<hr>\n<p>(e) <strong><em>&#8220;Proxy Expiration Date&#8221;<\/em><\/strong> means the earlier of<br \/>\n(i) the date upon which the Merger Agreement is validly terminated, or (ii) the<br \/>\ndate upon which the Merger becomes effective.<\/p>\n<p>(f) <strong><em>&#8220;Subject Securities&#8221;<\/em><\/strong> mean: (i) all of the<br \/>\nShares Owned by Stockholder as of the date of this Agreement; and (ii) all<br \/>\nadditional Shares of which Stockholder acquires Ownership during the Support<br \/>\nPeriod.<\/p>\n<p>(g) <strong><em>&#8220;Support Period&#8221;<\/em><\/strong> means the period commencing on<br \/>\n(and including) the date of this Agreement and ending on (and including) the<br \/>\nProxy Expiration Date.<\/p>\n<p>(h) A Person is deemed to have a effected a<br \/>\n<strong><em>&#8220;Transfer&#8221;<\/em><\/strong> of a security if such Person directly or<br \/>\nindirectly: (i) sells, pledges, encumbers, grants an option with respect to,<br \/>\ntransfers or disposes of such security or any interest in such security to any<br \/>\nPerson other than Parent; (ii) enters into an agreement or commitment<br \/>\ncontemplating the possible sale of, pledge of, encumbrance of, grant of an<br \/>\noption with respect to, transfer of or disposition of such security or any<br \/>\ninterest therein to any Person other than Parent; or (iii) reduces such Person&#8217;s<br \/>\nbeneficial ownership of, interest in or risk relating to such security.<\/p>\n<p><strong>SECTION 2. TRANSFER OF SUBJECT SECURITIES AND VOTING RIGHTS <\/strong>\n<\/p>\n<p><strong>2.1 Restriction on Transfer of Subject Securities.<\/strong> Subject<br \/>\nto Section 2.3, during the Support Period, Stockholder shall not cause or permit<br \/>\nany Transfer of any of the Subject Securities to be effected other than as<br \/>\nprovided in Section 3.1. Without limiting the generality of the foregoing,<br \/>\nduring the Support Period, Stockholder shall not tender, agree to tender or<br \/>\npermit to be tendered any of the Subject Securities in response to or otherwise<br \/>\nin connection with any tender or exchange offer other than the Offer.<\/p>\n<p><strong>2.2 Restriction on Transfer of Voting Rights.<\/strong> During the<br \/>\nSupport Period, Stockholder shall ensure that: (a) none of the Subject<br \/>\nSecurities is deposited into a voting trust; and (b) no proxy is granted, and no<br \/>\nvoting agreement or similar agreement is entered into, with respect to any of<br \/>\nthe Subject Securities.<\/p>\n<p><strong>2.3 Permitted Transfers.<\/strong> Section 2.1 shall not prohibit a<br \/>\ntransfer of Subject Securities by Stockholder: (a) if Stockholder is an<br \/>\nindividual (i) to any member of Stockholder&#8217;s immediate family, or to a trust<br \/>\nfor the benefit of Stockholder or any member of Stockholder&#8217;s immediate family,<br \/>\nor (ii) upon the death of Stockholder; (b) if Stockholder is a limited<br \/>\npartnership or limited liability company, to a partner or member of Stockholder<br \/>\nor (c) if Stockholder is a corporation, to an affiliate under common control<br \/>\nwith Stockholder; <em>provided<\/em>, <em>however<\/em>, that a transfer referred<br \/>\nto in this sentence shall be permitted only if, as a precondition to such<br \/>\ntransfer, the transferee agrees in a written document, reasonably satisfactory<br \/>\nin form and substance to Parent, to be bound by all of the terms of this<br \/>\nAgreement.<\/p>\n<p><strong>SECTION 3. TENDER OF SUBJECT SECURITIES <\/strong><\/p>\n<p><strong>3.1 Tender of Subject Securities. <\/strong>Unless this Agreement<br \/>\nshall have been terminated in accordance with its terms, Stockholder hereby<br \/>\nagrees to tender the Subject Securities (collectively, the <strong><em>&#8220;Tender<br \/>\nShares&#8221;<\/em><\/strong>), or instruct such Stockholder&#8217;s broker or such other<br \/>\nPerson that is the holder of record of the Tender Shares tendered, into the<br \/>\nOffer promptly following, and in any event no later than the tenth<br \/>\n(10<sup>th<\/sup>) business day following the commencement (within the meaning of<br \/>\nRule 14d-2 under the Exchange Act) of the Offer, or if Stockholder has not<br \/>\nreceived the Offer Documents by such time, within two (2) business days<br \/>\nfollowing receipt of such documents but in any event prior to the Expiration<br \/>\nDate. If Stockholder acquires Tender Shares after the date hereof, unless this<br \/>\nAgreement shall have been terminated in accordance with its terms, Stockholder<br \/>\nshall tender or cause to be tendered such Tender Shares on or before the<br \/>\nExpiration Date. Unless this Agreement shall have been terminated in accordance<br \/>\nwith its terms, Stockholder will not withdraw the Tender Shares, or cause the<br \/>\nTender Shares to be withdrawn, from the Offer at any time.<\/p>\n<p align=\"center\">-2-<\/p>\n<hr>\n<p><strong>3.2 Return of Subject Securities.<\/strong> If the Offer is terminated<br \/>\nor withdrawn by Purchaser, or the Merger Agreement is terminated prior to the<br \/>\npurchase of the Subject Securities in the Offer, Parent and Purchaser shall<br \/>\npromptly return, and shall cause any depository acting on behalf of Parent and<br \/>\nPurchaser to return, all Subject Securities tendered by Stockholder in the Offer<br \/>\nto Stockholder.<\/p>\n<p><strong>SECTION 4. VOTING OF SHARES <\/strong><\/p>\n<p><strong>4.1 Voting Covenant.<\/strong> Stockholder hereby agrees that, during<br \/>\nthe Support Period, at any meeting of the stockholders of the Company, however<br \/>\ncalled, and in any action by written consent of stockholders of the Company,<br \/>\nunless otherwise directed in writing by Parent, Stockholder shall cause the<br \/>\nSubject Securities to be voted:<\/p>\n<p>(a) in favor of (i) the Merger, the execution and delivery by the Company of<br \/>\nthe Merger Agreement and the adoption and approval of the Merger Agreement and<br \/>\nthe terms thereof, (ii) each of the other Transactions and (iii) and any action<br \/>\nin furtherance of any of the foregoing;<\/p>\n<p>(b) against any action or agreement that would result in a breach of any<br \/>\nrepresentation, warranty, covenant or obligation of the Company in the Merger<br \/>\nAgreement; and<\/p>\n<p>(c) against the following actions (other than the Merger and the other<br \/>\nTransactions): (i) any Acquisition Proposal; (ii) any amendment to the Company&#8217;s<br \/>\ncertificate of incorporation or bylaws; (iii) any material change in the<br \/>\ncapitalization of the Company or the Company&#8217;s corporate structure; and (iv) any<br \/>\nother action which is intended to impede, interfere with, delay, postpone,<br \/>\ndiscourage or adversely affect the Merger or any of the other Transactions or<br \/>\nthis Agreement.<\/p>\n<p><strong>4.2 Proxy; Further Assurances.<\/strong><\/p>\n<p>(a) (i) Contemporaneously with the execution of this Agreement, Stockholder<br \/>\nshall deliver to Parent a proxy in the form attached to this Agreement as<br \/>\nExhibit A, which shall be irrevocable (at all times prior to the Proxy<br \/>\nExpiration Date) to the fullest extent permitted by law with respect to the<br \/>\nshares referred to therein (the <strong><em>&#8220;Proxy&#8221;<\/em><\/strong>); and (ii)<br \/>\npromptly following the execution of this Agreement, Stockholder shall cause to<br \/>\nbe delivered to Parent an additional proxy (in substantially the form attached<br \/>\nhereto as Exhibit A) executed on behalf of the record owner of any outstanding<br \/>\nshares of Company Common Stock that are owned beneficially (within the meaning<br \/>\nof Rule 13d-3 under the Exchange Act), but not of record, by Stockholder.<\/p>\n<p>(b) Stockholder shall perform such further acts and execute such further<br \/>\nproxies and other documents and instruments as may reasonably be required to<br \/>\nvest in Parent the power to carry out and give effect to the provisions of this<br \/>\nAgreement.<\/p>\n<p>(c) Stockholder shall not enter into any tender, voting or other such<br \/>\nagreement, or grant a proxy or power of attorney, with respect to any of the<br \/>\nSubject Securities that is inconsistent with this Agreement or otherwise take<br \/>\nany other action with respect to any of the Subject Securities that would in any<br \/>\nway restrict, limit or interfere with the performance of any of Stockholder&#8217;s<br \/>\nobligations hereunder or any of the actions contemplated hereby.<\/p>\n<p align=\"center\">-3-<\/p>\n<hr>\n<p><strong>SECTION 5. WAIVER OF APPRAISAL RIGHTS <\/strong><\/p>\n<p>Stockholder hereby irrevocably and unconditionally waives, and agrees not to<br \/>\nexercise or assert, on its own behalf or on behalf of any other holder of<br \/>\nShares, any rights of appraisal, any dissenters&#8217; rights or any similar rights<br \/>\nrelating to the Merger that Stockholder may have by virtue of, or with respect<br \/>\nto, any Subject Securities Owned by Stockholder.<\/p>\n<p><strong>SECTION 6. REPRESENTATIONS AND WARRANTIES OF STOCKHOLDER <\/strong>\n<\/p>\n<p>Stockholder hereby represents and warrants to Parent and Purchaser as<br \/>\nfollows:<\/p>\n<p><strong>6.1 Authorization, etc.<\/strong> Stockholder has the authority and<br \/>\nlegal capacity to execute and deliver this Agreement and the Proxy and to<br \/>\nperform Stockholder&#8217;s obligations hereunder and thereunder. This Agreement and<br \/>\nthe Proxy have been duly authorized, executed and delivered by Stockholder and,<br \/>\nassuming due authorization, execution and delivery by Parent and Purchaser,<br \/>\nconstitute legal, valid and binding obligations of Stockholder, enforceable<br \/>\nagainst Stockholder in accordance with their terms, subject to (i) laws of<br \/>\ngeneral application relating to bankruptcy, insolvency, reorganization,<br \/>\nmoratorium, fraudulent conveyance and other laws affecting enforcement of<br \/>\ncreditors&#8217; rights generally and (ii) rules of law governing specific<br \/>\nperformance, injunctive relief and other equitable remedies. If Stockholder is a<br \/>\ncorporation, then Stockholder is a corporation duly organized, validly existing<br \/>\nand in good standing under the laws of the jurisdiction in which it was<br \/>\norganized. If Stockholder is a general or limited partnership or limited<br \/>\nliability company, then Stockholder is a partnership or limited liability<br \/>\ncompany duly organized, validly existing and in good standing under the laws of<br \/>\nthe jurisdiction in which it was organized.<\/p>\n<p><strong>6.2 No Conflicts or Consents. <\/strong><\/p>\n<p>(a) The execution and delivery of this Agreement and the Proxy by Stockholder<br \/>\ndo not, and the performance of this Agreement and the Proxy by Stockholder will<br \/>\nnot: (i) conflict with or violate any law, rule, regulation, order, decree or<br \/>\njudgment applicable to Stockholder or by which Stockholder or any of<br \/>\nStockholder&#8217;s properties is or may be bound, except for any conflict or<br \/>\nviolation which would not adversely affect in any material respect the ability<br \/>\nof Stockholder to perform its obligations hereunder or thereunder or consummate<br \/>\nthe transactions contemplated hereby; or (ii) result in or constitute (with or<br \/>\nwithout notice or lapse of time) any breach of or default under, or give to any<br \/>\nother Person (with or without notice or lapse of time) any right of termination,<br \/>\namendment, acceleration or cancellation of, or result (with or without notice or<br \/>\nlapse of time) in the creation of any Encumbrance on any of the Subject<br \/>\nSecurities pursuant to, any material Contract to which Stockholder is a party or<br \/>\nby which Stockholder or any of Stockholder&#8217;s Affiliates or properties is or may<br \/>\nbe bound or affected.<\/p>\n<p>(b) The execution and delivery of this Agreement and the Proxy by Stockholder<br \/>\ndo not, and the performance of this Agreement and the Proxy by Stockholder will<br \/>\nnot, require any filing with, nor any permit, authorization, consent or approval<br \/>\nof, any Person. The execution and delivery of any additional proxy pursuant to<br \/>\nSection 4.2(a)(ii) with respect to any shares of Company Common Stock that are<br \/>\nOwned beneficially but not of record by Stockholder do not, and the performance<br \/>\nof any such additional proxy will not, require any filing with, nor any permit,<br \/>\nauthorization, consent or approval of, any Person. No consent of, or<br \/>\nregistration, declaration or filing with, any Governmental Body is required to<br \/>\nbe obtained or made by or with respect to Stockholder in connection with the<br \/>\nexecution, delivery or performance of this Agreement or the consummation of the<br \/>\ntransactions contemplated hereby, other than such reports under Sections 13(d)<br \/>\nand 16 of the Exchange Act as may be required in connection with this Agreement.\n<\/p>\n<p align=\"center\">-4-<\/p>\n<hr>\n<p><strong>6.3 Title to Shares.<\/strong> As of the date of this Agreement<br \/>\nStockholder Owns, free and clear of any Encumbrance, the number of outstanding<br \/>\nShares set forth under the heading &#8220;Shares Owned&#8221; on the signature page hereof<br \/>\nand does not Own any other shares of capital stock of the Company or any right<br \/>\nto acquire any such shares.<\/p>\n<p><strong>6.4 Merger Agreement.<\/strong> Stockholder and its Representatives<br \/>\nhave reviewed and understand the terms of this Agreement and the Merger<br \/>\nAgreement, and Stockholder has had the opportunity to consult with such<br \/>\nStockholder&#8217;s counsel in connection with this Agreement. Stockholder understands<br \/>\nand acknowledges that Parent is entering into the Merger Agreement in reliance<br \/>\nupon Stockholder&#8217;s execution and delivery of this Agreement.<\/p>\n<p><strong>SECTION 7. REPRESENTATIONS AND WARRANTIES OF PARENT AND PURCHASER<br \/>\n<\/strong><\/p>\n<p>Each of Parent and Purchaser hereby, jointly and severally, represents and<br \/>\nwarrants to Stockholder as follows:<\/p>\n<p><strong>7.1 Authorization, etc.<\/strong> Each of Parent and Purchaser has all<br \/>\nnecessary corporate power and authority to execute and deliver this Agreement<br \/>\nand to perform its obligations hereunder. This Agreement has been duly<br \/>\nauthorized, executed and delivered by each of Parent and Purchaser and, assuming<br \/>\ndue authorization, execution and delivery by Stockholder, constitutes a legal,<br \/>\nvalid and binding obligation of Parent and Purchaser, enforceable against Parent<br \/>\nand Purchaser in accordance with its terms, subject to (i) laws of general<br \/>\napplication relating to bankruptcy, insolvency, reorganization, moratorium,<br \/>\nfraudulent conveyance and other laws affecting enforcement of creditors&#8217; rights<br \/>\ngenerally and (ii) rules of law governing specific performance, injunctive<br \/>\nrelief and other equitable remedies. Each of Parent and Purchaser is a<br \/>\ncorporation duly organized, validly existing and in good standing under the laws<br \/>\nof the jurisdiction in which it was organized.<\/p>\n<p><strong>7.2 No Conflicts or Consents. <\/strong>The execution and delivery of<br \/>\nthis Agreement by Parent and Purchaser does not, and the performance of this<br \/>\nAgreement by Parent and Purchaser will not: (a) conflict with or violate any<br \/>\nlaw, rule, regulation, order, decree or judgment applicable to Parent and<br \/>\nPurchaser or by which Parent or Purchaser or any of its properties is or may be<br \/>\nbound, except for any conflict or violation which would not adversely affect in<br \/>\nany material respect the ability of Parent or Purchaser to perform its<br \/>\nobligations hereunder or consummate the transactions contemplated hereby; or (b)<br \/>\nrequire any filing with, nor any permit, authorization, consent or approval of,<br \/>\nany Person or require any consent of, or registration, declaration or filing<br \/>\nwith, any Governmental Body, other than (i) any applicable requirements of the<br \/>\nExchange Act, NASDAQ, and the DGCL, (ii) as required by Antitrust Laws, (iii)<br \/>\ncontemplated by the Merger Agreement (including schedules thereto), and (iv)<br \/>\nwhere the failure to obtain such consents or approvals or to make such filings,<br \/>\nwould not, individually or in the aggregate, prevent or materially delay the<br \/>\nperformance by Parent or Purchaser of any of their obligations under this<br \/>\nAgreement.<\/p>\n<p><strong>SECTION 8. COVENANTS OF STOCKHOLDER <\/strong><\/p>\n<p><strong>8.1 Stockholder Information.<\/strong> Stockholder hereby agrees to<br \/>\npermit Parent and Purchaser to publish and disclose in the Proxy Statement<br \/>\nStockholder&#8217;s identity and ownership of the Subject Securities and the nature of<br \/>\nStockholder&#8217;s commitments, arrangements and understandings under this Agreement.\n<\/p>\n<p><strong>8.2 Further Assurances.<\/strong> From time to time and without<br \/>\nadditional consideration, Stockholder shall execute and deliver, or cause to be<br \/>\nexecuted and delivered, such additional transfers, assignments, endorsements,<br \/>\nproxies, consents and other instruments, and shall take such further actions, as<br \/>\nParent may request for the purpose of carrying out and furthering the intent of<br \/>\nthis Agreement.<\/p>\n<p align=\"center\">-5-<\/p>\n<hr>\n<p><strong>8.3 Stop Transfer Order; Legends.<\/strong> Stockholder hereby agrees<br \/>\nthat it will not request that the Company register the Transfer of any<br \/>\ncertificate or uncertificated interest representing any of the Subject<br \/>\nSecurities, unless such Transfer is made in compliance with this Agreement. In<br \/>\nfurtherance of this Agreement, concurrently herewith, Stockholder shall, and<br \/>\nhereby does authorize the Company or its counsel to, notify the Company&#8217;s<br \/>\ntransfer agent that there is a stop transfer order with respect to all of the<br \/>\nSubject Securities (and that this Agreement places limits on the voting and<br \/>\ntransfer of such shares). The parties hereto agree that such stop transfer order<br \/>\nshall be removed and shall be of no further force and effect upon the Proxy<br \/>\nExpiration Date.<\/p>\n<p><strong>SECTION 9. MISCELLANEOUS <\/strong><\/p>\n<p><strong>9.1 Survival of Representations, Warranties and Agreements.<\/strong><br \/>\nAll representations, warranties, covenants and agreements in this Agreement, and<br \/>\nall rights and remedies with respect thereto, shall not survive the Proxy<br \/>\nExpiration Date.<\/p>\n<p><strong>9.2 Expenses.<\/strong> All costs and expenses incurred in connection<br \/>\nwith the transactions contemplated by this Agreement shall be paid by the party<br \/>\nincurring such costs and expenses.<\/p>\n<p><strong>9.3 Notices.<\/strong> Each notice, request, demand or other<br \/>\ncommunication under this Agreement shall be in writing and shall be deemed to<br \/>\nhave been duly given, delivered or made as follows: (a) if delivered by hand,<br \/>\nwhen delivered; (b) if sent on a business day by email before 5:00 p.m. (Pacific<br \/>\ntime) and receipt is confirmed, when transmitted; (c) if sent by email on a day<br \/>\nother than a business day and receipt is confirmed, or if sent by email after<br \/>\n5:00 p.m. (Pacific time) and receipt is confirmed, on the business day following<br \/>\nthe date on which receipt is confirmed; (d) if sent by registered, certified or<br \/>\nfirst class mail, the third business day after being sent; and (e) if sent by<br \/>\novernight delivery via a national courier service, two business days after being<br \/>\ndelivered to such courier, in each case to the address or email set forth<br \/>\nbeneath the name of such party below (or to such other address or email as such<br \/>\nparty shall have specified in a written notice given to the other parties<br \/>\nhereto):<\/p>\n<p>if to Stockholder:<\/p>\n<p>at the address set forth on the signature page hereof;<\/p>\n<p>and if to Parent:<\/p>\n<p>Amgen Inc.<\/p>\n<p>One Amgen Center Drive<\/p>\n<p>Thousand Oaks, CA 91320-1799<\/p>\n<p>Attn: General Counsel<\/p>\n<p>with a copy to (which copy shall not constitute notice):<\/p>\n<p>Sullivan &amp; Cromwell LLP<\/p>\n<p>Attn: Eric M. Krautheimer<\/p>\n<p>1888 Century Park East, 21st Floor<\/p>\n<p>Los Angeles, California 90067<\/p>\n<p>Fax: (310) 712-8800<\/p>\n<p>Email: krautheimere@sullcrom.com<\/p>\n<p align=\"center\">-6-<\/p>\n<hr>\n<p><strong>9.4 Severability.<\/strong> If any term or provision of this Agreement<br \/>\nis invalid, illegal or incapable of being enforced by rule of law or public<br \/>\npolicy, all other conditions and provisions of this Agreement shall nevertheless<br \/>\nremain in full force and effect so long as the economic or legal substance of<br \/>\nthe transactions contemplated by this Agreement is not affected in any manner<br \/>\nadverse to any party. Upon such determination that any term or other provision<br \/>\nis invalid, illegal or incapable of being enforced, the parties hereto shall<br \/>\nnegotiate in good faith to modify this Agreement so as to effect the original<br \/>\nintent of the parties as closely as possible in an acceptable manner to the end<br \/>\nthat the transactions are fulfilled to the extent possible.<\/p>\n<p><strong>9.5 Entire Agreement; Amendment.<\/strong> This Agreement, the Proxy<br \/>\nand any other documents delivered by the parties in connection herewith<br \/>\nconstitute the entire agreement between the parties with respect to the subject<br \/>\nmatter hereof and thereof and supersede all prior agreements and understandings,<br \/>\nwritten or oral, between the parties with respect thereto. No amendment or<br \/>\nmodification of any provision of this Agreement shall be binding upon either<br \/>\nparty unless made in writing and signed by all parties. No agreement,<br \/>\nunderstanding or arrangement of any nature regarding the subject matter of this<br \/>\nAgreement shall be deemed to exist between Parent and Stockholder unless and<br \/>\nuntil this Agreement has been duly and validly executed on behalf of all<br \/>\nparties.<\/p>\n<p><strong>9.6 Assignment; Binding Effect.<\/strong> Except as provided herein,<br \/>\nneither this Agreement nor any of the interests or obligations hereunder may be<br \/>\nassigned or delegated by Stockholder, and any attempted or purported assignment<br \/>\nor delegation of any of such interests or obligations in violation of this<br \/>\nAgreement shall be void. Subject to the preceding sentence, this Agreement shall<br \/>\nbe binding upon Stockholder and Stockholder&#8217;s successors and assigns, and, if<br \/>\nStockholder is an individual, Stockholder&#8217;s heirs, estate, executors and<br \/>\npersonal representatives. This Agreement shall inure to the benefit of Parent<br \/>\nand its successors and assigns. Without limiting any of the restrictions set<br \/>\nforth in Section 2 or elsewhere in this Agreement, this Agreement shall be<br \/>\nbinding upon any Person to whom any Subject Securities are transferred. Nothing<br \/>\nin this Agreement, expressed or implied, is intended to confer on any Person,<br \/>\nother than the parties hereto, any rights or remedies of any nature.<\/p>\n<p><strong>9.7 Independence of Obligations.<\/strong> The covenants and<br \/>\nobligations of Stockholder set forth in this Agreement shall be construed as<br \/>\nindependent of any other agreement or arrangement between Stockholder, on the<br \/>\none hand, and the Company or Parent, on the other. The existence of any claim or<br \/>\ncause of action by Stockholder against the Company or Parent shall not<br \/>\nconstitute a defense to the enforcement of any of such covenants or obligations<br \/>\nagainst Stockholder.<\/p>\n<p><strong>9.8 Specific Performance.<\/strong> The parties hereto acknowledge<br \/>\nthat money damages would be an inadequate remedy for any breach of this<br \/>\nAgreement by any party hereto, and that the obligations of the parties hereto<br \/>\nshall be enforceable by any party hereto through injunctive or other equitable<br \/>\nrelief.<\/p>\n<p><strong>9.9 Governing Law. <\/strong>This Agreement shall be governed by, and<br \/>\nconstrued and enforced in accordance with, the laws of the State of Delaware,<br \/>\nregardless of the laws that might otherwise govern under applicable principles<br \/>\nof conflicts of laws thereof.<\/p>\n<p><strong>9.10 Counterparts.<\/strong> This Agreement may be executed in<br \/>\nseparate counterparts, each of which when so executed and delivered shall be an<br \/>\noriginal, but all such counterparts shall together constitute one and the same<br \/>\ninstrument. The exchange of a fully executed Agreement (in counterparts or<br \/>\notherwise) by facsimile or by electronic delivery shall be sufficient to bind<br \/>\nthe parties to the terms of this Agreement.<\/p>\n<p><strong>9.11 Waiver. <\/strong>No failure on the part of Parent to exercise<br \/>\nany power, right, privilege or remedy under this Agreement, and no delay on the<br \/>\npart of Parent in exercising any power, right, privilege or remedy under this<br \/>\nAgreement, shall operate as a waiver of such power, right, privilege or remedy;<br \/>\nand no single or partial exercise of any such power, right, privilege or remedy<br \/>\nshall preclude any other or further exercise thereof or of any other power,<br \/>\nright, privilege or remedy. Parent shall not be deemed to have<\/p>\n<p align=\"center\">-7-<\/p>\n<hr>\n<p>waived any claim available to Parent arising out of this Agreement, or any<br \/>\npower, right, privilege or remedy of Parent under this Agreement, unless the<br \/>\nwaiver of such claim, power, right, privilege or remedy is expressly set forth<br \/>\nin a written instrument duly executed and delivered on behalf of Parent; and any<br \/>\nsuch waiver shall not be applicable or have any effect except in the specific<br \/>\ninstance in which it is given.<\/p>\n<p><strong>9.12 Termination. <\/strong>This Agreement and all rights and<br \/>\nobligations of the parties hereunder, including the Proxy, shall terminate, and<br \/>\nno party shall have any rights or obligations hereunder and this Agreement shall<br \/>\nbecome null and void on, and have no further effect as of the Proxy Expiration<br \/>\nDate. Nothing in this Section 9.12 shall relieve any party from any liability<br \/>\nfor any breach of this Agreement prior to its termination.<\/p>\n<p><strong>9.13 Directors and Officers. <\/strong>This Agreement applies to<br \/>\nStockholder solely in such Stockholder&#8217;s capacity as a holder of Subject<br \/>\nSecurities, and not to Stockholder or any representative of Stockholder serving<br \/>\nas a director or officer of the Company in such capacity.<\/p>\n<p><strong>9.14 Construction. <\/strong><\/p>\n<p>(a) For purposes of this Agreement, whenever the context requires: the<br \/>\nsingular number shall include the plural, and vice versa; the masculine gender<br \/>\nshall include the feminine and neuter genders; the feminine gender shall include<br \/>\nthe masculine and neuter genders; and the neuter gender shall include masculine<br \/>\nand feminine genders.<\/p>\n<p>(b) The parties agree that any rule of construction to the effect that<br \/>\nambiguities are to be resolved against the drafting party shall not be applied<br \/>\nin the construction or interpretation of this Agreement.<\/p>\n<p>(c) As used in this Agreement, the words &#8220;include&#8221; and &#8220;including,&#8221; and<br \/>\nvariations thereof, shall not be deemed to be terms of limitation, but rather<br \/>\nshall be deemed to be followed by the words &#8220;without limitation.&#8221;<\/p>\n<p>(d) Unless otherwise indicated or the context otherwise requires: (i) all<br \/>\nreferences in this Agreement to &#8220;Sections&#8221; and &#8220;Exhibits&#8221; are intended to refer<br \/>\nto Sections of this Agreement and Exhibits to this Agreement; and (ii) the words<br \/>\n&#8220;herein,&#8221; &#8220;hereof&#8221; and &#8220;hereunder,&#8221; and words of similar import, shall be<br \/>\nconstrued to refer to this Agreement in its entirety and not to any particular<br \/>\nprovision of this Agreement.<\/p>\n<p>(e) The captions contained in this Agreement are for convenience of reference<br \/>\nonly, shall not be deemed to be a part of this Agreement and shall not be<br \/>\nreferred to in connection with the construction or interpretation of this<br \/>\nAgreement.<\/p>\n<p align=\"center\"><em>[Remainder of page intentionally left blank] <\/em><\/p>\n<p align=\"center\">-8-<\/p>\n<hr>\n<p>Parent, Purchaser and Stockholder have caused this Agreement to be executed<br \/>\nas of the date first written above.<\/p>\n<table style=\"width: 40%; border-collapse: collapse;\" width=\"40%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"100%\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p><strong>A<\/strong><strong>MGEN<\/strong><strong><br \/>\nI<\/strong><strong>NC<\/strong><strong>.<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>By:<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>Title<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p><strong>A<\/strong><strong>RMSTRONG<\/strong><strong><br \/>\nA<\/strong><strong>CQUISITION<\/strong><strong><br \/>\nC<\/strong><strong>ORP<\/strong><strong>.<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>By:<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>Title<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p><strong>S<\/strong><strong>TOCKHOLDER<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>Signature<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>Printed Name<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"right\">\n<table style=\"width: 40%; border-collapse: collapse;\" width=\"40%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"19%\"><\/td>\n<td width=\"1%\" valign=\"bottom\"><\/td>\n<td width=\"80%\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"2\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p>Address:<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"2\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<td valign=\"bottom\"><\/td>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"2\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<td valign=\"bottom\"><\/td>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"2\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p>Facsimile:<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"2\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<td valign=\"bottom\"><\/td>\n<td valign=\"top\">\n<p align=\"right\">Shares Owned<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr>\n<p align=\"center\"><strong>E<\/strong><strong>XHIBIT<\/strong><strong> A <\/strong>\n<\/p>\n<p align=\"center\"><strong>F<\/strong><strong>ORM<\/strong><strong><br \/>\nO<\/strong><strong>F<\/strong><strong><br \/>\nI<\/strong><strong>RREVOCABLE<\/strong><strong> P<\/strong><strong>ROXY<\/strong>\n<\/p>\n<p>The undersigned stockholder (the <strong><em>&#8220;Stockholder&#8221;<\/em><\/strong>) of<br \/>\nMicromet, Inc., a Delaware corporation (the<br \/>\n<strong><em>&#8220;Company&#8221;<\/em><\/strong>), hereby irrevocably (to the fullest extent<br \/>\npermitted by law) appoints and constitutes Kevin W. Sharer, Robert A. Bradway,<br \/>\nJonathan M. Peacock, David J. Scott and Amgen Inc., a Delaware corporation<br \/>\n(<strong><em>&#8220;Parent&#8221;<\/em><\/strong>), and each of them, the attorneys and<br \/>\nproxies of the Stockholder, with full power of substitution and resubstitution,<br \/>\nto the full extent of the Stockholder&#8217;s rights with respect to (i) the<br \/>\noutstanding shares of capital stock of the Company owned of record by the<br \/>\nStockholder as of the date of this proxy, which shares are specified on the<br \/>\nfinal page of this proxy, and (ii) any and all other shares of capital stock of<br \/>\nthe Company which the Stockholder may acquire on or after the date hereof. (The<br \/>\nshares of the capital stock of the Company referred to in clauses &#8220;(i)&#8221; and<br \/>\n&#8220;(ii)&#8221; of the immediately preceding sentence are collectively referred to as the<br \/>\n<strong><em>&#8220;Shares&#8221;<\/em><\/strong>). Upon the execution hereof, all prior<br \/>\nproxies given by the Stockholder with respect to any of the Shares are hereby<br \/>\nrevoked, and the Stockholder agrees that no subsequent proxies will be given<br \/>\nwith respect to any of the Shares.<\/p>\n<p>This proxy is irrevocable, shall survive the Stockholder&#8217;s death, liquidation<br \/>\nor termination, is coupled with an interest and is granted in connection with,<br \/>\nand as security for, the Tender and Support Agreement, dated as of the date<br \/>\nhereof, among Parent, Armstrong Acquisition Corp., a wholly-owned subsidiary of<br \/>\nParent (<strong><em>&#8220;Purchaser&#8221;<\/em><\/strong>), and the Stockholder (the<br \/>\n<strong><em>&#8220;Support Agreement&#8221;<\/em><\/strong>), and is granted in consideration<br \/>\nof Parent and Purchaser entering into the Agreement and Plan of Merger, dated as<br \/>\nof the date hereof, among Parent, Purchaser and the Company (as it may be<br \/>\namended from time to time, the <strong><em>&#8220;Merger Agreement&#8221;<\/em><\/strong>).<br \/>\nThis proxy will terminate on the Proxy Expiration Date (as defined in the<br \/>\nSupport Agreement). Capitalized terms not defined in this Proxy or in the<br \/>\nSupport Agreement shall have the respective meanings assigned to those terms in<br \/>\nthe Merger Agreement.<\/p>\n<p>The attorneys and proxies named above will be empowered, and may exercise<br \/>\nthis proxy, to vote the Shares at any time until (and including) the Proxy<br \/>\nExpiration Date at any meeting of the stockholders of the Company, however<br \/>\ncalled, and in connection with any action by written consent of stockholders of<br \/>\nthe Company:<\/p>\n<p>(i) in favor of (A) the merger contemplated by the Merger Agreement (the<br \/>\n<strong><em>&#8220;Merger&#8221;<\/em><\/strong>), the execution and delivery by the Company<br \/>\nof the Merger Agreement and the adoption and approval of the Merger Agreement<br \/>\nand the terms thereof, (B) each of the other Transactions and (C) any action in<br \/>\nfurtherance of any of the foregoing;<\/p>\n<p>(ii) against any action or agreement that would result in a breach of any<br \/>\nrepresentation, warranty, covenant or obligation of the Company in the Merger<br \/>\nAgreement; and<\/p>\n<p>(iii) against the following actions (other than the Merger and the other<br \/>\nTransactions): (A) any Acquisition Proposal; (B) any amendment to the Company&#8217;s<br \/>\ncertificate of incorporation or bylaws; (C) any material change in the<br \/>\ncapitalization of the Company or the Company&#8217;s corporate structure; and (D) any<br \/>\nother action which is intended to impede, interfere with, delay, postpone,<br \/>\ndiscourage or adversely affect the Merger or any of the other Transactions or<br \/>\nthis Support Agreement.<\/p>\n<p>The Stockholder may vote the Shares on all other matters not referred to in<br \/>\nthis proxy, and the attorneys and proxies named above may not exercise this<br \/>\nproxy with respect to such other matters.<\/p>\n<p>This proxy shall be binding upon the heirs, estate, executors, personal<br \/>\nrepresentatives, successors and assigns of the Stockholder (including any<br \/>\ntransferee of any of the Shares).<\/p>\n<p align=\"center\">A-1<\/p>\n<hr>\n<p>If any term or provision of this proxy is invalid, illegal or incapable of<br \/>\nbeing enforced by rule of law or public policy, all other conditions and<br \/>\nprovisions of this proxy shall nevertheless remain in full force and effect so<br \/>\nlong as the economic or legal substance of the transactions contemplated by this<br \/>\nproxy is not affected in any manner adverse to any party. Upon such<br \/>\ndetermination that any term or other provision is invalid, illegal or incapable<br \/>\nof being enforced, Parent and Stockholder shall negotiate in good faith to<br \/>\nmodify this proxy so as to effect their original intent as closely as possible<br \/>\nin an acceptable manner to the end that the transactions are fulfilled to the<br \/>\nextent possible.<\/p>\n<p>Dated: January 25, 2012<\/p>\n<table style=\"width: 40%; border-collapse: collapse;\" width=\"40%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"100%\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p><strong>S<\/strong><strong>TOCKHOLDER<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>Signature<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>Printed Name<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p>Number of shares of common stock of the Company owned of record as of the<br \/>\ndate of this proxy:<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\">A-2<\/p><\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[6691],"corporate_contracts_industries":[9405],"corporate_contracts_types":[9622,9626],"class_list":["post-43765","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-amgen-inc","corporate_contracts_industries-drugs__biotech","corporate_contracts_types-planning","corporate_contracts_types-planning__merger"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43765"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43765"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43765"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}